Business
Bluebird Bio Stock Is in Free Fall
[ad_1] Two weeks ago, bluebird bio secured Food and Drug Administration approval for its gene therapy for sickle cell disease, a significant milestone for…
Tag: CH:NOVN
Breaking News
Novartis Raises 2023 View
[ad_1] By Adria Calatayud Novartis raised its full-year earnings guidance for the third time this year after it reported higher net profit and sales…
Breaking News
Novartis Says Kidney Drug Phase 3 Trial Reaches Positive Interim Result
[ad_1] By Adria Calatayud Novartis said an interim analysis from a phase 3 trial to evaluate its investigational iptacopan drug in patients with kidney…
Breaking News
Novartis Sets Sandoz Spinoff Date for Oct. 4
[ad_1] By Adria Calatayud Novartis said the planned spinoff of its Sandoz generic pharmaceuticals and biosimilars business is expected to occur on or around…
Business
Bank of America, Morgan Stanley, Lockheed, Masimo, Novartis, and More Stock Market Movers
[ad_1] We’ve detected you are on Internet Explorer. For the best Barrons.com experience, please update to a modern browser. Summary Summary U.S Europe Asia…